Century Therapeutics Inc. (IPSC)
0.92
-0.02 (-1.63%)
At close: Jan 15, 2025, 2:25 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -136.67M | -130.93M | -95.82M | -53.58M | -244.77M |
| Depreciation & Amortization | 13.04M | 8.44M | 3.75M | 1.40M | 249.00K |
| Stock-Based Compensation | 14.62M | 10.67M | 4.66M | 876.00K | 147.00K |
| Other Working Capital | 11.74M | 128.73M | -949.00K | 2.80M | 1.03M |
| Other Non-Cash Items | 11.28M | 1.93M | 1.21M | 444.00K | 225.95M |
| Deferred Income Tax | n/a | n/a | n/a | 4.72M | n/a |
| Change in Working Capital | 9.38M | 123.94M | -2.80M | 4.86M | 2.26M |
| Operating Cash Flow | -88.35M | 14.05M | -89.00M | -41.27M | -16.17M |
| Capital Expenditures | -13.74M | -30.60M | -44.97M | -9.82M | -2.46M |
| Acquisitions | n/a | -238.22M | -30.34M | -4.72M | 24.17M |
| Purchase of Investments | -209.03M | -254.00M | -330.03M | -49.86M | -41.54M |
| Sales Maturities Of Investments | 283.90M | 271.48M | 76.67M | 41.65M | -24.17M |
| Other Investing Acitivies | n/a | 238.22M | 30.34M | -4.72M | 24.17M |
| Investing Cash Flow | 61.13M | -13.13M | -298.34M | -22.76M | -19.83M |
| Debt Repayment | -10.24M | n/a | n/a | 9.73M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 196.16M | 37.96M | 74.84M |
| Financial Cash Flow | -9.72M | 27.16M | 417.77M | 47.69M | 74.84M |
| Net Cash Flow | -36.94M | 28.08M | 30.43M | -16.34M | 38.84M |
| Free Cash Flow | -102.08M | -16.55M | -133.97M | -51.09M | -18.63M |